04/15/2024
On Tax Day, a manuscript of ours has been accepted at iScience. Congrats to Dr. Cai and the rest of the team.
The pre-print can be found there:
https://pubmed.ncbi.nlm.nih.gov/37662374
04/04/2024
The American Cancer Society is going to fund a research scholar grant for our team. The funded research will be to investigate the crosstalk between fatty acid metabolisms and the biophysical tumor microenvironment. The project will be commenced in Jan 2025 and completed in 2029.
04/02/2024
Our new paper at JBC has been online. This paper will help us further understand the mechanisms of Hippo pathway regulation and mechanotransduction.
https://www.jbc.org/article/S0021-9258(24)01754-X/fulltext
03/11/2024
Our research has been funded by the Bankhead-Coley Cancer Research Program at the Florida Department of Health. This is a prestigious 3-year grant that enables us to further explore the impacts of diet and lifestyles on obesity and liver metabolic diseases.
04/23/2023
Our collaboration with Dr. Charles Huang’s lab has won us a Provost’s Research Award. We look forward to publishing the exciting results very soon.
04/11/2022
Our paper on Semaphorin and Hippo signaling in tumor growth, angiogenesis, and mechanosensing has been officially accepted by Science Advances.
Dr. Zhipeng Meng is a co-corresponding author, and Dr. Ying Wang and Dr. Xiaomin Cai are co-authors of this study.
10/20/2021
Our collaborator Dr. Rongze Lu’s R01 to NINDS has received a great score.
Great achievement for an ESI (12%). As the co-I of the grant, we are thrilled and look forward to working with Dr. Rongze Lu on the proposed experiments!
09/21/2021
The Elsa U. Pardee Foundation has funded our breast cancer research!
A grant of $182,429.00 will support our research on identifying new therapies for Triple-Negative Breast Cancer.
06/22/2021
Our First NIH Grant!!!
We have been funded by a 5-year NIGMS-MIRA (R35) grant. The major goals of this project are to understand the molecular mechanisms by which mechanical cues regulate tissue regeneration and fibrosis via a Non-Canonical Hippo pathway.
06/01/2021
Dr. Zhipeng Meng has been funded by Stanley J. Glaser Foundation.
This award is to support a breast cancer project in Dr. Meng’s lab. The major goals of this project are to identify regulatory mechanisms and therapeutic potential of a novel Semaphorin-Hippo signaling in Triple Negative Breast Cancer.
05/24/2021
Our first paper has been online now:
https://www.frontiersin.org/articles/10.3389/fcell.2021.673599/full
Opening:
Several positions for graduate students and postdocs are available in our lab. Please email zxm282@miami.edu for more information.
GET IN TOUCH
Meng Lab at University of Miami 